Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 285

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Bleeding Risk with Dabigatran in the Frail Elderly

Open access
Harper, Paul, Young, Laura, Merriman, Eileen · 2012 · New England Journal of Medicine

Abstract

In response to Eikelboom and Weitz: when prescribing a drug with side effects that include life-threatening hemorrhage, reversal is not "desirable," it is essential.Our letter to the Editor never mentioned prothrombin complex concentrates.Rapid reversal is indeed associated with reduced morbidity and mortality.[1][2][3] Thromboelastography detects the effects of dabigatran within minutes (and the values for activated clotting time were markedly prolonged in all the patients described in our letter).Partialthromboplastin times were normal.The dilutethrombin-time assay with dabigatran calibrators is currently labeled for research use only.Eikelboom and Weitz state the deaths could not be attributed to "lack of an antidote."These patients were receiving dabigatran and presented with coagulopathy, and the multidisciplinary team caring for them could not control their hemorrhages.Next, although an absolute reduction of 0.2 percentage points in intracranial hemorrhage may be statistically significant (in 18,000 patients), this may not be clinically meaningful.4 Finally, they state that a lack of an antidote should not deter physicians from prescribing dabigatran.We hope all prescribers will take note of the Food and Drug Administration alert re-garding dabigatran and, in doing so, expand the risk-benefit conversation with their patients.5

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc1112874

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 285

Metadata

Authors
Harper, P., Young, L., & Merriman, E.
Venue
New England Journal of Medicine
Published
2012-03
Volume
366
Issue
9
Pages
864-866
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1975650244
Cited by
285
References
2
FWCI
37.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bleeding Risk with Dabigatran in the Frail Elderly. https://app.cochat.ai/papers/10.1056/nejmc1112874
The paper
Harper, P., Young, L., & Merriman, E. (2012). Bleeding Risk with Dabigatran in the Frail Elderly. New England Journal of Medicine. https://doi.org/10.1056/nejmc1112874

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.